The effect of the COVID-19 lockdown on mental health care use in South Africa: an interrupted time-series analysis.
Alcohol abuse
health service research
psychiatric hospital
psychiatric services
Journal
Epidemiology and psychiatric sciences
ISSN: 2045-7979
Titre abrégé: Epidemiol Psychiatr Sci
Pays: England
ID NLM: 101561091
Informations de publication
Date de publication:
15 Jun 2022
15 Jun 2022
Historique:
entrez:
15
6
2022
pubmed:
16
6
2022
medline:
18
6
2022
Statut:
epublish
Résumé
The coronavirus disease 2019 (COVID-19) pandemic and ensuing restrictions have negatively affected the mental health and well-being of the general population, and there is increasing evidence suggesting that lockdowns have led to a disruption of health services. In March 2020, South Africa introduced a lockdown in response to the COVID-19 pandemic, entailing the suspension of all non-essential activities and a complete ban of tobacco and alcohol sales. We studied the effect of the lockdown on mental health care utilisation rates in private-sector care in South Africa. We conducted an interrupted time-series analysis using insurance claims from 1 January 2017 to 1 June 2020 of beneficiaries 18 years or older from a large private sector medical insurance scheme. We calculated weekly outpatient consultation and hospital admission rates for organic mental disorders, substance use disorders, serious mental disorders, depression, anxiety, other mental disorders, any mental disorder and alcohol withdrawal syndrome. We calculated adjusted odds ratios (OR) for the effect of the lockdown on weekly outpatient consultation and hospital admission rates and the weekly change in rates during the lockdown until 1 June 2020. 710 367 persons were followed up for a median of 153 weeks. Hospital admission rates (OR 0.38; 95% confidence interval (CI) 0.33-0.44) and outpatient consultation rates (OR 0.74; 95% CI 0.63-0.87) for any mental disorder decreased substantially after the introduction of the lockdown and did not recover to pre-lockdown levels by 1 June 2020. Health care utilisation rates for alcohol withdrawal syndrome doubled after the introduction of the lockdown, but the statistical uncertainty around the estimates was large (OR 2.24; 95% CI 0.69-7.24). Mental health care utilisation rates for inpatient and outpatient services decreased substantially after the introduction of the lockdown. Hospital admissions and outpatient consultations for alcohol withdrawal syndrome increased after the introduction of the lockdown, but statistical uncertainty precludes strong conclusions about a potential unintended effect of the alcohol sales ban. Governments should integrate strategies for ensuring access and continuity of essential mental health services during lockdowns in pandemic preparedness planning.
Identifiants
pubmed: 35703078
doi: 10.1017/S2045796022000270
pii: S2045796022000270
pmc: PMC9245492
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e43Subventions
Organisme : NIAID NIH HHS
ID : U01 AI069924
Pays : United States
Organisme : NIH HHS
ID : U01AI069924
Pays : United States
Organisme : Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
ID : 193381
Organisme : Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
ID : 189498
Références
J Affect Disord. 2021 Jul 1;290:279-283
pubmed: 34015622
Eur Arch Psychiatry Clin Neurosci. 2010 Aug;260(5):385-91
pubmed: 19911248
J Affect Disord. 2015 Apr 1;175:224-8
pubmed: 25658495
PLoS One. 2021 Jun 30;16(6):e0253805
pubmed: 34191850
Lancet Reg Health Eur. 2021 Mar;2:100034
pubmed: 34173630
Lancet Public Health. 2020 Oct;5(10):e543-e550
pubmed: 32979305
Pediatr Emerg Care. 2021 Aug 1;37(8):427-434
pubmed: 34074990
Lancet. 2021 Nov 6;398(10312):1700-1712
pubmed: 34634250
Prog Neuropsychopharmacol Biol Psychiatry. 2021 Aug 30;110:110304
pubmed: 33737215
Epidemiol Psychiatr Sci. 2020 Sep 29;29:e173
pubmed: 32988427
Front Public Health. 2021 Apr 30;9:593307
pubmed: 33996706
Lancet. 2020 Mar 14;395(10227):912-920
pubmed: 32112714
Lancet. 2017 Dec 17;388(10063):3048-3059
pubmed: 27349358
Br J Psychiatry. 2014 Aug;205(2):88-94
pubmed: 25252316
Lancet Psychiatry. 2021 Oct;8(10):892-900
pubmed: 34332697
Lancet Digit Health. 2021 Apr;3(4):e217-e230
pubmed: 33612430
J Stroke Cerebrovasc Dis. 2020 Oct;29(10):105114
pubmed: 32912527
J Affect Disord. 2021 Mar 1;282:26-32
pubmed: 33387743
BMJ Glob Health. 2021 Feb;6(2):
pubmed: 33627361
PLoS One. 2021 Jan 22;16(1):e0245546
pubmed: 33481848
Lancet Psychiatry. 2021 Jun;8(6):535-550
pubmed: 33639109
Emerg Med Australas. 2021 Apr;33(2):316-323
pubmed: 33070468
J Affect Disord. 2020 Dec 1;277:55-64
pubmed: 32799105
Lancet Psychiatry. 2020 Sep;7(9):813-824
pubmed: 32682460
Lancet HIV. 2021 Mar;8(3):e158-e165
pubmed: 33549166
JAMA Netw Open. 2021 Feb 1;4(2):e2037227
pubmed: 33576819
JAMA Intern Med. 2020 Oct 1;180(10):1328-1333
pubmed: 32744612
Epidemiol Psychiatr Sci. 2021 Feb 15;30:e20
pubmed: 33583474
Psychol Med. 2020 Nov 27;:1-8
pubmed: 33243311
Int Clin Psychopharmacol. 2016 Nov;31(6):347-52
pubmed: 27384739